Department of Gastroenterology, Cumhuriyet University School of Medicine, Sivas, Turkey
Kaan Gökçen
Department of Urology, Cumhuriyet University School of Medicine, Sivas, Turkey
Erol Çakmak
Department of Gastroenterology, Cumhuriyet University School of Medicine, Sivas, Turkey
Gökhan Gökçe
Department of Urology, Cumhuriyet University School of Medicine, Sivas, Turkey
Gökçen, P., Gökçen, K., Çakmak, E., & Gökçe, G. (2019). Paraneoplastic hyperbilirubinemia in metastatic prostate cancer and review of the current literature . Urology Research and Practice, 45(1), 70–72. https://doi.org/10.5152/tud.2018.52059
Paraneoplastic syndromes are functional clinical disorders caused by the direct effect of the primary tumor or metastasis. The initial presenting symptom of the patients may be associated with paraneoplastic manifestations. Paraneoplastic cholestasis is most frequently defined in association with renal cell carcinoma (Stauffer's syndrome), but it is an extremely rare clinical entity seen in association with prostate cancer. Etiology of cholestasis was investigated in the case diagnosed as metastatic prostate cancer who applied to the gastroenterology outpatient clinic due to complaints of ascites and jaundice that established the diagnosis of paraneoplastic hyperbilirubinemia. We observed improvement of his cholestasis with hormonotherapy used for prostate cancer.
Cite this article as: Gökçen P, Gökçen K, Çakmak E, Gökçe G. Paraneoplastic hyperbilirubinemia in metastatic prostate cancer and review of the current literature. Turk J Urol 2019; 45(1): 70-2.
Department of Gastroenterology, Cumhuriyet University School of Medicine, Sivas, Turkey
Kaan Gökçen
Department of Urology, Cumhuriyet University School of Medicine, Sivas, Turkey
Erol Çakmak
Department of Gastroenterology, Cumhuriyet University School of Medicine, Sivas, Turkey
Gökhan Gökçe
Department of Urology, Cumhuriyet University School of Medicine, Sivas, Turkey
Cite this Article
Gökçen, P., Gökçen, K., Çakmak, E., & Gökçe, G. (2019). Paraneoplastic hyperbilirubinemia in metastatic prostate cancer and review of the current literature . Urology Research and Practice, 45(1), 70–72. https://doi.org/10.5152/tud.2018.52059